Bulletin
Investor Alert

May 25, 2020, 9:20 a.m. EDT

Stocks Trading At Their Highest Volume: $BIOC $TLRY $TTOO

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Biocept Inc. (BIOC)
  • X
    Tilray Inc. Cl 2 (TLRY)
  • X
    T2 Biosystems Inc. (TTOO)

or Cancel Already have a watchlist? Log In

May 25, 2020 (The Market Signal via Comtex) -- Sector Reports was created as a platform to help investors find the best free Stock Reports on stocks they own. If you are a shareholder or looking for stocks to buy /zigman2/quotes/206998585/composite BIOC +2.00% , /zigman2/quotes/209129655/composite TLRY -0.43% or /zigman2/quotes/206664517/composite TTOO -14.97% then we strongly urge you to join our community by signing up with the link below and getting a completely free research report on each company today.

http://www.sectorreports.com.au/Free-Report/NOW

(Click link above or copy, paste and hit enter in your browser for your report)

Biocept Reported 41% Hiked Revenue in Q1 2020 from A Year Before

https://www.sectorreports.com.au/landing-page/?symbol=BIOC

(Click link above or copy, paste and hit enter in your browser for your report)

Biocept Inc /zigman2/quotes/206998585/composite BIOC +2.00% gained 9.83% on a volume of 46.35 million shares. A leading provider of molecular technologies recently announced Q1 2020 financial result for the period ended March 31, 2020. The company reported that it generated revenues of $1.4 million in Q1 2020, representing a 41% hike from a year before. This is attributed to a 27% increase in revenue per commercial accession.

Michael Nall, President and CEO of Biocept, said, "Headwinds of COVID-19 pandemic led to an approximate 15-25% decline in commercial volume from current customers."

Revenues for Q1 2020 are inclusive of $1.3 million in commercial test revenue, while $60,000 in development services test revenue. This revenue also includes $69,000 for distributed products, Target Selector

(TM)
RUO kits, and CEE-Sure(R) blood collection tubes.

Tilray Sees 11% Revenue Hike as People Stock Pile Marijuana in Lockdown

https://www.sectorreports.com.au/landing-page/?symbol=TLRY

(Click link above or copy, paste and hit enter in your browser for your report)

Tilray Inc ( NASDAQ: TLRY ) gained 6.32% on a volume of 42.89 million shares. Headwinds from coronavirus pandemic lockdown created a positive impact on the sales of Tilray's marijuana. Cannabis has been deemed a part of "essential service," resulting in a surge in sales. Sales from marijuana at places where Tilray operates increased company's revenue 11% sequentially in recently reported quarter that ended in March.

On May 12, the pot producer of Canada reported that it incurred smaller-than-expected losses after it had begun its cost-cutting program. The company also added that it hoping to achieve positive cash flow by the end of December.

Burst of marijuana demand was a result of pantry-loading as well as people's efforts to pile up products before stay-at-home orders.

T2 Biosystems Generated Q1 2020 Total Revenue of $2.5 Million, 43% Hike

https://www.sectorreports.com.au/landing-page/?symbol=TTOO

(Click link above or copy, paste and hit enter in your browser for your report)

/zigman2/quotes/206998585/composite
US : U.S.: Nasdaq
$ 1.02
+0.02 +2.00%
Volume: 13.65M
Aug. 12, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$131.10 million
Rev. per Employee
$35,642
loading...
/zigman2/quotes/209129655/composite
US : U.S.: Nasdaq
$ 6.90
-0.03 -0.43%
Volume: 5.33M
Aug. 12, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$887.68 million
Rev. per Employee
$62,689
loading...
/zigman2/quotes/206664517/composite
US : U.S.: Nasdaq
$ 1.59
-0.28 -14.97%
Volume: 16.51M
Aug. 12, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$223.54 million
Rev. per Employee
$68,628
loading...
/zigman2/quotes/206998585/composite
US : U.S.: Nasdaq
$ 1.02
+0.02 +2.00%
Volume: 13.65M
Aug. 12, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$131.10 million
Rev. per Employee
$35,642
loading...
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.